GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (LTS:0GRP) » Definitions » Revenue

Biotage AB (LTS:0GRP) Revenue : kr1,981 Mil (TTM As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Revenue?

Biotage AB's revenue for the three months ended in Mar. 2024 was kr480 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr1,981 Mil. Biotage AB's Revenue per Share for the three months ended in Mar. 2024 was kr6.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr25.51.

Good Sign:

Biotage AB has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Biotage AB was 9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Biotage AB's highest 3-Year average Revenue per Share Growth Rate was 30.30% per year. The lowest was -10.70% per year. And the median was 12.30% per year.


Biotage AB Revenue Historical Data

The historical data trend for Biotage AB's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Revenue Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,101.37 1,092.00 1,232.00 1,566.00 1,862.00

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 361.00 409.00 449.00 643.00 480.00

Competitive Comparison of Biotage AB's Revenue

For the Medical Instruments & Supplies subindustry, Biotage AB's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Revenue distribution charts can be found below:

* The bar in red indicates where Biotage AB's Revenue falls into.



Biotage AB Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,981 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB  (LTS:0GRP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Biotage AB Revenue Related Terms

Thank you for viewing the detailed overview of Biotage AB's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (LTS:0GRP) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (LTS:0GRP) Headlines

No Headlines